News
Digistain – EIT Health Catapult 2023-2024 semi-finalist
Delighted to have been selected by EIT Health as a semi-finalist.
Delighted to have been selected by EIT Health as a semi-finalist.
LONDON – 19 JULY 2023: A health-economic study commissioned by the UK government modelled potential NHS savings from using Digistain under stated assumptions. The study,
We are presenting a poster at the ESMO Breast Cancer Annual Congress (#ESMOBreast23) from 11-13 May in Berlin. The poster reports the prognostic performance of
Team Digistain with Prof Sir Mike Dixon OBE at the American Society of Breast Surgeons Annual Symposium this year where we were honored to be
Honoured today to be offered a place on NHS Oxford’s UK Access Program! #digitalhealth #accelerator
Delighted to be shortlisted as a finalist at the Medilink Business Awards 2023 for not one but two categories! Advances in Digital Health and for
Thankful for the opportunity to unveil our latest clinical study at San Antonio Breast Cancer Symposium this week! #sabcs2022 #oncology #breastcancer
Pleased to be on the radio again talking about our mission here at Digistain to improve access to recurrence-risk testing.
On the BBC today talking about British patient access to emerging technologies and the challenges health-tech companies face in the widespread adoption of their technologies
Excited to be in Boston, MA for the Med Tech Conference. Here Digistain is keeping up to date on the latest health-tech updates and regulatory
Digistain wins the Institute of Physics Innovation Business Start-Up Award 2022 @PhysicsNews for a biomedical implementation of infrared vibrational spectroscopy.
To stay updated about Digistain’s developments, enter your details opposite. We promise only to send you important news.
